Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer

This cross-sectional study evaluates the prevalence of proton pump inhibitor use among patients with cancer at 4 French comprehensive cancer centers.

Detalles Bibliográficos
Autores principales: Raoul, Jean-Luc, Guérin-Charbonnel, Catherine, Edeline, Julien, Simmet, Victor, Gilabert, Marine, Frenel, Jean-Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209575/
https://www.ncbi.nlm.nih.gov/pubmed/34132796
http://dx.doi.org/10.1001/jamanetworkopen.2021.13739
Descripción
Sumario:This cross-sectional study evaluates the prevalence of proton pump inhibitor use among patients with cancer at 4 French comprehensive cancer centers.

Ejemplares similares